We wish to express our deepest condolences for the victims and their families of the Pacific coast of Tohoku Earthquake.
We sincerely hope that the afflicted areas can realize a quick recovery.

News

February 20, 2012
Eli Lilly has introduced Redevant (pitavastatin), an HMG-CoA reductase inhibitor for lowering cholesterol, in Mexico this month.
The launch comes after the product received approval in July 2011 from the country's Ministry of Health.
November 10, 2011
Kowa Announces the Efficacy and Safety of a Novel Phosphodiesterase 3 Inhibitor K-134 for the Treatment of Intermittent Claudication in AHA 2011
August 04, 2011
Mexican health authority has granted marketing authorization for pitavastatin，an HMG-CoA reductase inhibitor or statin，for treatment of hyperlipidemia.
Kowa’s partner，Eli Lilly will market the product as Redevant® from early 2012.
May 11, 2011
The HMG-CoA reductase inhibitor pitavastatin calcium (Livazo 1mg, 2mg & 4mg) has been launched in Spain on May 2, 2011 as the first European market.
Spain is co-marketed by Recordati S.p.A and ESTEVE

Back numbers